key: cord-1045538-8ab1plnd
authors: Youssef, Alexey; Kouchaki, Samaneh; Shamout, Farah; Armstrong, Jacob; El‐Bouri, Rasheed; Taylor, Thomas; Birrenkott, Drew; Vasey, Baptiste; Soltan, Andrew; Zhu, Tingting; Clifton, David A.; Eyre, David W.
title: Development and validation of early warning score systems for COVID‐19 patients
date: 2021-05-27
journal: Healthc Technol Lett
DOI: 10.1049/htl2.12009
sha: 4d83db51e90c08f44e96c343ae59434fb458f2c3
doc_id: 1045538
cord_uid: 8ab1plnd

COVID‐19 is a major, urgent, and ongoing threat to global health. Globally more than 24 million have been infected and the disease has claimed more than a million lives as of November 2020. Predicting which patients will need respiratory support is important to guiding individual patient treatment and also to ensuring sufficient resources are available. The ability of six common Early Warning Scores (EWS) to identify respiratory deterioration defined as the need for advanced respiratory support (high‐flow nasal oxygen, continuous positive airways pressure, non‐invasive ventilation, intubation) within a prediction window of 24 h is evaluated. It is shown that these scores perform sub‐optimally at this specific task. Therefore, an alternative EWS based on the Gradient Boosting Trees (GBT) algorithm is developed that is able to predict deterioration within the next 24 h with high AUROC 94% and an accuracy, sensitivity, and specificity of 70%, 96%, 70%, respectively. The GBT model outperformed the best EWS (LDTEWS:NEWS), increasing the AUROC by 14%. Our GBT model makes the prediction based on the current and baseline measures of routinely available vital signs and blood tests.

the limited resources there is a significant need to prioritise the right patients so the resource is available for those who need it. Deterioration prediction tools have traditionally existed in the form of Early Warning Score (EWS) systems or Physiological Track and Trigger Systems, which track physiological variables and alert for assistance when the variables surpass a predefined threshold [1] . EWS systems use an aggregate weighted scoring of vital signs and other variables [2] . Early EWS were not intended to predict adverse events, but rather to alert for deterioration that may precede adverse events. Currently, different scores have been developed, adjusted and validated to predict the adverse events themselves as a proxy for deterioration [1] .

Current EWS systems are based on routinely measured physiological variables and different laboratory markers [2] [3] [4] [5] [6] . Common examples include the NEWS [6] , CEWS [2] , MCEWS [3] , AEWS [7] , LDTEWS [8] , and LDTEWS:NEWS [4] (which combines both NEWS and LDTEWS), among others. The scores evaluate physiological parameters (NEWS, CEWS, MCEWS and AEWS), laboratory parameters (LDTEWS) and a combination of physiological and laboratory parameters (LDTEWS:NEWS) ( Table 1) [2] [3] [4] [6] [7] [8] . The scores have been validated for different outcomes, including ICU admission, mortality, and cardiac arrest, usually within 24 h from the time of measurement (Table 1) . It is unclear how EWS systems would perform in COVID-19 patients, since these scores have been developed and validated to discriminate deterioration in a prepandemic general inpatient cohort. By contrast, deterioration in the COVID-19 inpatient cohort more commonly manifests through hypoxic respiratory failure [9] . Therefore, the EWS tools built may be less effective at predicting deterioration in COVID-19 patients. For example, NEWS considers a binary variable for oxygen support (room air vs. oxygen support) while the rest of the variables are either continuous or categorical [6] .

NEWS is, thus, not equipped to capture the variability in oxygen support levels which are a strong proxy for COVID-19 severity. Despite the limitations, these tools are in routine use in many hospital managing patients with Some of the existing EWS systems have been validated on COVID-19 patients [10] [11] [12] [13] [14] . Meylan et al. and Carr et al. have adjusted NEWS2 to adapt it for COVID-19 patients [15, 16] . Carr and colleagues validated the ability of the NEWS2 score to identify severe COVID-19 infections (defined as ICU admission or in-hospital mortality). The study reported an initial performance of 0.628 area under the receiving operator characteristic curve (AUROC) and a performance of 0.753 AUROC after including five additional predictive features: age, c-reactive protein (CRP), neutrophil count, estimated glomerular filtration rate (GFR), and albumin [15] . The Royal College of Physicians has endorsed the use of (NEWS2) to predict deterioration of COVID-19 patients [17] . While NEWS2 have been evaluated, many scores are still not evaluated appropriately, including NEWS, CEWS, MCEWS, AEWS, LDTEWS, and LDTEWS:NEWS. It is critical to evaluate the performance of different available EWS on a COVID-19 inpatient population, to inform clinical practice during the global pandemic. Improperly validated EWS systems and predictive models are of limited clinical benefit in pandemic settings and their risk of harm can potentially outweigh the promised benefit [18] [19] [20] .

In response to the aforementioned clinical and research need to validate EWS in COVID-19 patients, our work has three main contributions: (i) we evaluate the performance of existing EWS systems ( Table 1 ) that may be currently used in practice to predict clinical deterioration in COVID-19 patients, (ii) we develop and validate machine learning models to predict deterioration in advance for COVID-19 patients, and (iii) we compare between machine learning methods and traditional EWS systems. 

We defined the outcome of deterioration as either an escalation in the level of oxygen support requirements to either a level 2 or level 3 delivery device, or an unplanned ICU admission within a window of 24 h. To do this, we created four levels of oxygen support based on the respiratory support device used (level 0: room air, level 1: low-flow oxygen support devices (flow less than 10 L/min, e.g. nasal cannulae), level 2: oxygen support devices with a flow over 10 L/min (e.g. reservoir bag), and level 3: high-flow ventilation or invasive ventilation). A detailed list of the oxygen support devices used to make the classification is available in Table S5 in Supporting Information. We have defined progression to level 2 or 3 devices as an escalation to high-level oxygen support; therefore, a patient who progressed from L0 or L1 to L2/L3/unanticipated ICU admission would be considered to have deteriorated, while a transition from L0 to L1 would not be considered a deterioration. L2 indicates a deterioration in the condition of the patient and an increase in the need for respiratory support, while L3 is an advanced level of support that is dependent on respiratory support equipment that is in limited supply (i.e. ventilators or NIV equipment). Outside the scope of this paper, predicting L0 to L1 deterioration can be clinically valuable as it would differentiate patients who can be discharged (patients on room air who do not require oxygen support) from those who need hospital admission (requiring L1 or above support), and a trigger for starting dexamethasone therapy [21, 22] . However, we hypothesised that identifying the patients who need (L3) or are expected to need (L2) the advanced level of support would be more valuable because it provides the clinical teams the opportunity to optimise the management of resources that are in short supply during an event like a pandemic.

We investigated the performance of (i) a basic machine learning classifier: logistic regression (LR) and (ii) two ensemble learning methods: Random Forest (RF) and Gradient Boosting Trees (GBT). Details of each method, parameter settings, and their strengths and weaknesses are shown in Table S7 in Supporting Information.

To evaluate the EWS performance and compare it with that of the machine learning models, multiple feature sets were considered (Table 2) . To ensure fairness, we first established a baseline comparison on the same feature sets as employed by each EWS. For example, the vital signs feature set is used by NEWS, CEWS, MCEWS, AEWS, and hence their performance was compared with a machine learning model using the same input features. Similarly, for the EWS bloods feature set (used by LDTEWS) and the vital signs and EWS bloods feature set (LDTEWS:NEWS), the same inputs were considered for the comparative machine learning models. In addition, we trained and evaluated the machine learning models on various other feature sets. Six sets of clinical parameters were investigated: (1) 24 routinely collected laboratory blood tests, (2) 21 routinely measured/estimated point-of-care blood gas readings, (3) changes in vital signs results in a window of 24 h before the given observation, (4) measurements of seven routinely measured physiological parameters, (5) variance of the current vital signs from a baseline of a previous admission, and (6) variance of the current vital signs, blood tests, and blood gases from a baseline of a previous admission. The components of each feature set are detailed in Table 2 . Pre-existing oxygen support before the point of prediction was indicated by a binary variable (1 for L1 support and 0 for L0 support) ( Table S5 in Supporting Information). Consequently, we considered the following feature sets for machine learning analysis: (vital signs-F1) vital signs ; (EWS bloods-F2) EWS bloods feature set; (EWS blood and vital signs-F3) a combination of F1 and F2 feature sets; (blood tests-F4) clinical parameters in (1); (blood gas-F5) clinical markers in (2) 

Fraction of inspired oxygen (FiO 2 ) values (%) were calculated based on the mask type used. Depending on the mask type, oxygen flow (O 2 flow, L/min) and patient's respiratory rate (RR, breaths/min) were included in the calculation. Simple face masks, nebuliser masks, tracheostomy masks and Oxy-Masks were considered as Hudson masks. 

We treated observation sets as independent rather than as grouped by patient admission. We excluded implausible physiological values. Non-numerical readings were replaced with clinically appropriate values. Where a lab value was reported as being below the threshold of detection of the laboratory assay, the value was replaced with a numerical zero value. Where values were reported as being above the threshold of detection, clinically appropriate values were selected to maintain the significance of the high result. When the provision or absence of supplemental oxygen was missing, we assumed that supplemental oxygen was not provided and set the supplemental oxygen value to 0. Similarly, we have made the same assumption for AVPU and replaced missing AVPU values by 'alert'. For missing values, we have used multiple imputation techniques (mean, median, Bayesian ridge regression, and stochastic regression) to compensate for missing values across the dataset. The best performing imputation method across different experiments was median, hence we have chosen it as the default method in our analysis as a design choice ( Figure S1 in Supporting Information).

The evaluated EWS systems (Table 3) are provided with default alerting thresholds to convert the computed score to 'alert' or 'no alert'. NEWS gives an individual score of 2 when a patient is on supplementary oxygen, and an individual score of 0 when the patient is on room air. NEWS aggregates the individual scores to an overall score which is assessed against an alerting threshold (default 5). We used the default individual scores for EWS. However, given that we are predicting an outcome different from the default predicted outcome of the EWS (escalation in oxygen demand vs. in-hospital mortality, cardiac arrest or unplanned ICU admission), we chose to evaluate the performance of the EWS not only based on the original overall thresholds (e.g. 5 for NEWS) but also on optimised thresholds. We optimised the machine learning and EWS thresholds to report the performance metrics on the test set by identifying the thresholds that maximise the accuracy on the train dataset, and used these thresholds on the test set.

For all experiments, the classification was performed by training on a balanced dataset and then testing on an imbalanced (representative) dataset. We ran the classification over multiple iterations and cross-fold validations. In each fold, 20% of the data was considered as the test set. Within the remaining 80% of the data, since non-events outnumbered events, nonevents were sub-sampled randomly to balance the size of the two classes. This was run over 40 iterations of 5-fold stratified cross-validation. We chose k-fold stratified due to the imbalanced nature of the classes. For machine learning, GBT, RF, and LR were considered as basic machine learning techniques (Table S7 in Supporting  Information) . For EWS, the test set was used to calculate EWS scores in each fold.

We evaluated the performance of our EWS and machine learning methods using the AUROC to predict an outcome of deterioration defined as either escalation in the level of oxygen demand (to level 2 or 3) (Table S5 in Supporting Information) or an unplanned ICU admission. The performance in terms of accuracy, sensitivity, specificity, precision, and AUROC were calculated for the validation sets (for parameter setting) and test sets (for final comparison) and averaged over iterations; mean and standard deviation were reported.

TP, TN, FP, and FN stand for true positive, true negative, false positive, and false negative, respectively. Considering a probability estimate as the output of each classifier for the validation set and setting various thresholds to categorise this output as event/non-event could result in different TP, FP, FN, and TN rates. Alternatively, a receiver operating characteristic (ROC) curve showing the sensitivity as a function of 1specificity for different thresholds; each point in the curve indicates a specific value for sensitivity, specificity, and accuracy. AUROC-ROC is the area under the ROC curve.

The parameters of the models (e.g. number of ensembles for RF or GBT) were optimised through the internal crossvalidation on the training data. This was done by a grid search over a range of values and selecting parameters that generated the best AUROC-ROC. The model with the highest performance was reported in the paper.

The IORD panel, which includes patient and public representatives provided feedback on the study design and approved its final form.

Our study is retrospective, using data extracted from electronic health records (EHR). The dataset contains routinely collected observations from concluded hospital admissions from four hospitals within the Oxford University Hospitals (OUH) NHS Foundation Trust. OUH consists of 4 teaching hospitals in Oxfordshire, UK, serving a population of 600,000 and providing tertiary referral services to the surrounding region. Data were obtained between March and July 2020.

Our dataset included 15,686 sets of observations from 472 admissions in 472 unique patients. The dataset included 137 respiratory deterioration events (observing each patient until discharge or their first deterioration). The average age was 68 ± 16 (mean ± std) and 47% (221/472 patients) of the dataset were females. The mean and interquartile ranges (IQR) of the blood, blood gas, and vital sign parameters are in the supplementary materials (Tables S2-S4 in Supporting Information).

We defined respiratory deterioration as the need for advanced respiratory support (high-flow nasal oxygen [HFN0], continuous positive airways pressure [CPAP], NIV(intubation) or ICU admission within a prediction window of 24 h. It should be noted, however, that hypoxic respiratory failure is not the only process through which COVID-19 patients deteriorate as some patients deteriorate through a process of shock due to venous thromboembolism or super-added sepsis. Such events may also lead to ICU admission or increased oxygen requirements and so still be captured by our model. Table 3 outlines the performance of the EWS systems. NEWS, MCEWS, CEWS, AEWS, LDTEWS:NEWS, and LDTEWS achieved an AUROC of 79%, 78%, 63%, 68%, 80%, 62%, respectively. The best performing scores were NEWS and LDTEWS:NEWS ( Figure 1 ). The efficiency curve of the various EWS systems is outlined in Figure 1 .

We evaluated the performance of the recommended (original) thresholds for the different EWS. The default thresholds are 5, 4, 4, 0.27, 0.33 for NEWS, CEWS, MCEWS, LDTEWS:NEWS, and LDTEWS, respectively. AEWS does not have a recommended threshold, therefore we have excluded it from the evaluation of the recommended thresholds. The NEWS score had the most balanced sensitivity and specificity (66% and 75%, respectively). NEWS and LDTEWS achieved the lowest accuracy (75% and 73%) with a sensitivity and specificity of 41% and 74% for LDTEWS. CEWS achieved the highest accuracy (91%) but with a sensitivity of 23% and specificity of 91% (Table 3) .

We optimised the thresholds for each score to maximise accuracy as outlined in the Methods Section. Optimised EWS thresholds yielded more balanced performance. LDTEWS:NEWS was the overall best performing score with an accuracy, sensitivity, and specificity of 67%, 77% and 67%, respectively. NEWS, MCEWS, CEWS, and AEWS achieved high accuracy (62%, 61%, 64%, 60%, respectively). The worst performing score was LDTEWS with an accuracy of 52% and AUROC of 62%. The accuracy-optimised thresholds for all scores differed from the recommended values (Table 3) .

The performance of the EWS in COVID-19 patients was significantly lower than that previously reported in non-COVID patients. The Royal College of Physicians [6] reported a performance of (AUROC = 89%) for NEWS compared to (AUROC = 79%) in our dataset. Watkinson and colleagues [3] reported a performance of (AUROC = 86.8% and AUROC = 80.8%) for MCEWS and CEWS, respectively. This compares to AUROC values of 78% and 63% for MCEWS and CEWS in our dataset. Shamout and colleagues [7] reported that AEWS achieved an AUROC of 83.8%, while AEWS achieved a performance of 68% on COVID patients in our dataset. Redfern and colleagues reported an AUROC of 90.1-91.6% for LDTEWS:NEWS. In COVID patients, the AUROC for LDTEWS:NEWS was 80%. The worst performing score in our study was LDTEWS (AUROC of 62%). The score was developed by Jarvis and colleagues [8] with a reported AUROC that ranges between 75% and 80% in discriminating in-hospital mortality among the gen-eral in-hospital patient cohort. This indicates that while the predictors used in LDTEWS (HGB, Alb, Na, k, Cr, Ur, WBC) are useful to discriminate in-hospital mortality in non-COVID, they are less useful in predicting respiratory deterioration in COVID patients (Table 1 ).

We evaluated the performance of three machine learning models (GBT, RF, and LR) on the training data using an internal 5-fold cross-validation. We evaluated the performance of the machine learning models on multiple feature sets as outlined in the feature sets subsection of the Methods and Table 2 (F1-F11). The GBT model outperformed the other models on the different features sets in our training dataset. Therefore, we made a design choice to use only the GBT model when evaluating the performance on the different feature sets in the test data. The highest AUROC was achieved using the F1 (AUROC of 83%), F7 (AUROC of 93%), F8 (AUROC of 86%), F9 (AUROC of 94%), and F11 (AUROC of 93%) feature sets. The lowest AUROC was observed in the F2 (AUROC of 72%), F4 (AUROC of 77%), F5 (AUROC of 69%), and F6 (AUROC of 78%) feature sets. The F7 dataset is a simple feature set that is based on 6 commonly collected vital signs and their variability. F7 could represent the scenario of an overrun healthcare facility in which access to lab tests may not be easily accessible and readily available.

We compared the performance of the EWS systems and machine learning models to predict COVID-19 patient deterioration in three main feature sets: F1-F3 (Table 2 ). In each of the three feature sets, the machine learning model outperformed the EWS systems. For the F1 feature set, we can compare the performance of NEWS (AUROC = 79%), MCEWS (AUROC = 78%), CEWS (AUROC = 63%), and AEWS (AUROC = 68%) with the performance of GBT (AUROC = 83%). For the F2 feature set, we can compare the performance of LDTEWS (AUROC = 62%) with the performance of GBT (AUROC = 72%). For the F3 set, we can compare the performance of LDTEWS:NEWS (AUROC = 80%) with the performance of GBT (AUROC = 85%) (Figure 1 ). The efficiency curve of machine learning EWS systems is outlined in Figure 1 .

The overall best performing algorithm for machine learning models was the GBT model on the F9 feature set (AUROC = 94%). Given the imbalanced nature of our dataset, we have decided to tune the probability-class conversion threshold for the GBT model to create the best performing machine learning model. We decided to optimise the threshold to maximise accuracy. We identified the threshold that maximises the accuracy of the GBT model on the training set and measured the performance on the test set. The identified threshold was 0.19. The optimised GBT model achieved an accuracy, sensitivity, and specificity of 70%, 96%, and 70%, respectively. The most and least important features are outlined in Table 4 . Out of the 10 most important features (FiO 2 , min-max SBP, CRP, max-min HR, PO 2 , mean cell volume, arterial blood calcium, max-min RR, CtO 2 C, temp), four belonged to the F7 (vital signs and variability) feature set, three belonged to the F5 feature set (arterial blood tests), and two belonged to the F4 feature set (venous blood tests). The most important feature was FiO 2 . Delta is a measure of variability of a specific variable, it is calculated as (current value-the mean in the last 24 h). The most important vital signs were heart rate, respiratory rate, temperature, and blood oxygen saturation (SpO 2 ).

We conducted three additional experiments. The first was to limit the predictors of the GBT model to the top features that ranked the highest on the feature importance scale considering the training set. We found that the optimal number of features was 18-20 and subsequently chose to report the performance on the 20 most important features. This forward selection experiment did not impact performance (Table 4 ). We did not attempt a backward selection approach in this study, which is considered preferable in classical statistics. The second experiment was to include a more granular measurement of oxygen support. We included the Fraction of Inspired Oxygen (FiO 2 ) for this aim. Including the FiO 2 did not improve the performance ( Table 4 ). The third experiment was to include age as a predictor. Including age as a predictor did not significantly impact the performance ( Table 4 ). The lack of performance gains in spite of the high feature importance may be due to multicolinearity, where a subset of existing variables highly correlate with this feature. This is explicit in the construction of the FiO 2 variable, which is calculated from source variables already present in the vital signs feature set (respiratory rate, SpO 2 , Masktype) as outlined in the Methods section.

Our results show that summary measures of variability of vital signs and laboratory markers play an important role in predicting deterioration. Adding the variability (range, mean of previous 24-h window) and delta (current value -mean) features to the vital signs feature set added 10% points to the AUROC (vital signs 83% vs. vital signs and variations 93%). Similar results were observed in the all features feature set, where adding the variability and delta predictors added 8% points to AUROC (all features 86% vs. all features and variations 94%). Adding the delta baseline variables to both the all feature and vital signs feature spaces has improved the performance (vital signs and variations and baseline 93%; all features and variations and baseline 93%). These observations echo common clinical practice where physicians often analyse trends of parameters rather than their absolute values when evaluating a patient and highlight the benefits of dynamic monitoring. Moreover, the importance of summarising the variability and changes of vital signs when using them as inputs for machine learning models has already been demonstrated by Shamout and colleagues [26] in their work to develop a deep learning-based early warning system.

The lower performance of the model when using variables from blood gas analysis could partly be explained by inconsistency in the labelling of these samples. The origin of the blood, whether venous or arterial, was frequently missing or mislabelled perhaps reflecting time pressures on clinical staff, or skewed where interest is towards markers minimally influenced by sample provenance (e.g. lactate). This required the use of imputation techniques during the preprocessing of the dataset, which may have had an effect on performance. Moreover, some data points in blood gas readings duplicated information encoded within other feature sets, such as haemoglobin and creatinine.

To assess for biases in model performance, we assessed rates of patient misclassification during validation for the best performing machine learning technique. We observed that rates of misclassification were higher for white (44%) than black, Asian and minority ethnic group patients (22%). The misclassification rate was similar between men (47%) and women (42%) and between patients aged over 60 (43%) and patients aged between 18 and 60 (44%). The difference in performance may be explained by feature differences across ethnicity groups including genetic and blood biomarkers. 

Here, we assess the performance of existing EWS for predicting escalation to high-level oxygen support or unplanned ICU admission; this is an area of clinical importance in COVID-19. The EWS studied have been previously validated for predicting events such as cardiac arrest, unplanned ICU admission or death (Table 1) . However, limitations of using death as an outcome measure include that the score may be identifying an early sign of an already irreversible process, and therefore early identification of this may offer limited opportunity for clinical intervention. By contrast, our COVID-19 focused outcome measure provides a clinically useful and actionable warning which may help clinicians and healthcare system managers to preempt shortages and optimise resource allocation in a pandemic context. The difference in performance between our model and the EWS could be partially explained by the fact that these EWS were developed and optimised to detect ward patients' deterioration against different outcomes. Nonetheless, these EWS represent the current standard of care for COVID-19 patients, and we took action to mitigate these effects by optimising each EWS threshold for our COVID-19 inpatient cohort. The alerting threshold for EWS systems should be optimised according to the requirements of the clinical settings, taking into account that sensitivity and specificity are usually inversely correlated and that high false alert rate (calculated as False positive rate = 1 -specificity) leads to alert 'fatigue' and inefficient use of clinical resources. Within the prediction window of 24 h (Table 4) , our machine learning EWS system achieves a specificity that ranges between 70% to 82%, which means a false positive rate of 30% to 18%. Future iterations of the system will aim to increase specificity by including comorbidities, using transfer learning, considering a larger dataset, and employing more advanced models. A strength of our machine learning approach is its interpretability, using methods employed elsewhere in clinical practice [27] and shown able to attain patient and clinician trust. The three selected models (GBT, RF, and LR) permit querying of variables' weights and presentation in an explainable way. This ability to make sense of the algorithm decision-making process has repeatedly been described as a critical factor in increasing technology uptake in clinical practice [28] . Moreover, our feature sets are oriented around routinely collected clinical data collected within existing care pathways, including calculation of EWS scores. Our models are therefore rapidly deployable within current clinical pathways.

A relative limitation of our study is that the number of features approximates that of patients within the training set. There is consequently a risk of overfitting when considering all the clinical features available, as exemplified by the increase in performance when limiting our inputs to the 20 most influential variables. Additionally, while a prediction window >1 h before an event is in line with existing vital monitoring systems [27] , the window between sets of vital signs and positive events may capture overlapping transition effects. For example, an escalation in FiO 2 may represent an emergency response to physio-logical deterioration which is necessarily followed by escalation of oxygen delivery device and ICU admission (where that level of support can be provided). Therefore, predictions made after a rapid escalation in FiO 2 may capture patients where a clinical deterioration has already occurred, and ICU admission/higher level respiratory support is presently being arranged. Increasing the window upper bound to 3 h before an escalation event had minimal effect on performance. On examination, the majority of escalation events (109/137) contained observations within a 12-24 h prior window. Therefore, our data suggests that this is not a significant limitation in our case. Another limitation of our study is that we have not included pre-existing conditions in our analysis. Pre-existing conditions have shown to play an important role in increasing the risk of COVID-19 deterioration. Therefore, future research efforts should include a preexisting conditions as predictive features in COVID-19 predictive models. Moreover, while we hypothesise that multicolinearity could explain why the addition of FiO 2 did not increase AUROC, we did not explore multicolinearity between the different features in our dataset. This could be a valuable piece of analysis to explore in future research efforts.

The multivariate nature of EWS permit partial scores to be calculated where data is missing, however the machine learning methods examined require prior handling of missing data. These can be challenging to impute, as clinical data is often not missing at random. Missing data may therefore be poorly represented by population average values; for example, recording of vital signs is performed less frequently where there is no clinical concern. Limitations of imputation strategies include also the loss of important metadata. The presence of a measurement can often encode clinical meaning, for example, the presence of an arterial blood gas reading is often driven by clinical concern of respiratory compromise; semantic knowledge which is lost by imputation. Nonetheless, in this study we demonstrate minimal difference in model performance across a range of imputation strategies on model performances, demonstrating minimal difference. By contrast, the multivariate, interpretable nature of EWS permit a partial score to be calculate despite missingness.

Here, we assessed the theoretical performance of three machine learning approaches against some of the current EWS. We demonstrated that the performance of EWS in COVID-19 patients is sub-optimal. We also present a machine learning Early Warning System with AUROC of 94%. Translation to clinical practice requires further optimisation and prospective valuation in a representative clinical population. Such optimisations include a better understanding of the dynamic evolution and availability of clinical data in real time in the healthcare setting. Calibration of alarm trigger thresholds should be guided by desired clinical performance, reflecting healthcare system resource constraints and priorities, and a product design accounting for an optimal human-computer interaction.

In defence of early warning scores

Centile-based early warning scores derived from statistical distributions of vital signs

Tarassenko Lionel Manual centile-based early warning scores derived from statistical distributions of observational vital-sign data

Predicting in-hospital mortality and unanticipated admissions to the intensive care unit using routinely collected blood tests and vital signs: Development and validation of a multivariable model

Watkinson Peter J. A comparison of the ability of the National Early Warning Score and the National Early Warning Score 2 to identify patients at risk of in-hospital mortality: A multi-centre database study

The National Early Warning Score Development and Implementation Group

A Early warning score adjusted for age to predict the composite outcome of mortality, cardiac arrest or unplanned intensive care unit admission using observational vital-sign data: a multicentre development and validation

Development and validation of a decision tree early warning score based on routine laboratory test results for the discrimination of hospital mortality in emergency medical admissions

Ning Qin Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study

Huang Jiao Acute Physiology and Chronic Health Evaluation II Score as a Predictor of Hospital Mortality in Patients of Coronavirus Disease

Myrstad Marius Covid-19: Symptomer, forløp og bruk av kliniske skåringsverktøy hos de 42 første pasientene innlagt på et norsk lokalsykehus

Gordini Giovanni New Early Warning Score: off-label approach for Covid-19 outbreak patient deterioration in the community

Qiu Yanru Comparing Rapid Scoring Systems in Mortality Prediction of Critically Ill Patients With Novel Coronavirus Disease

Hanratty Barbara National Early Warning Scores And COVID-19 Deaths In Care Homes: An Ecological

Evaluation and improvement of the National Early Warning Score (NEWS2) for COVID-19: a multi-hospital study

Calandra Thierry An Early Warning Score to predict ICU admission in COVID-19 positive patients

Royal College of Physicians (RCP). NEWS2 and deterioration in COVID-19

Smeden Maarten Prediction models for diagnosis and prognosis of covid-19: systematic review and critical appraisal

Calibration of Risk Prediction Models

Limited utility of SOFA and APACHE II prediction models for ICU triage in pandemic influenza

Specialty guides for patient management during the coronavirus pandemic Guidance for the role and use of non-invasive respiratory support in adult patients with coronavirus (confirmed or suspected)

Dexamethasone in hospitalized patients with Covid-19

Beckert Lutz Measurement of oxygen concentration delivered via nasal cannulae by tracheal sampling

Performance of six types of oxygen delivery devices at varying respiratory rates*

The effect of fractional inspired oxygen concentration on early warning score performance: A database analysis

Deep Interpretable Early Warning System for the Detection of Clinical Deterioration

Risk prediction of critical vital signs for ICU patients using recurrent neural network

What clinicians want: Contextualizing explainable machine learning for clinical end use

This research was supported by the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC). The views expressed are those of the authors and not necessarily those of the NHS, the NIHR or the Department of Health. Alexey Youssef acknowledges the Rhodes Trust.

Alexey Youssef https://orcid.org/0000-0003-0621-1522 Andrew Soltan https://orcid.org/0000-0003-2391-5361